Data Insights

Tinostamustine by Mundipharma EDO for Mycosis Fungoides: Likelihood of Approval

Tinostamustine is under clinical development by Mundipharma EDO and currently in Phase I for Mycosis Fungoides. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - Tinostamustine in Mycosis Fungoides

Data Insights

Tinostamustine by Mundipharma EDO for Sezary Syndrome: Likelihood of Approval

Tinostamustine is under clinical development by Mundipharma EDO and currently in Phase I for Sezary Syndrome. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - Tinostamustine in Sezary Syndrome

Data Insights

Tinostamustine by Mundipharma EDO for T-Cell Leukemia: Likelihood of Approval

Tinostamustine is under clinical development by Mundipharma EDO and currently in Phase I for T-Cell Leukemia. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - Tinostamustine in T-Cell Leukemia

Data Insights

Tinostamustine by Mundipharma EDO for Diffuse Large B-Cell Lymphoma: Likelihood of Approval

Tinostamustine is under clinical development by Mundipharma EDO and currently in Phase I for Diffuse Large B-Cell Lymphoma. According to...

Data Insights

Tinostamustine by Northlake International for Multiple Myeloma (Kahler Disease): Likelihood of Approval

Tinostamustine is under clinical development by Northlake International and currently in Phase I for Multiple Myeloma (Kahler Disease). According to...

Data Insights

Tinostamustine by Mundipharma EDO for Mantle Cell Lymphoma: Likelihood of Approval

Tinostamustine is under clinical development by Mundipharma EDO and currently in Phase I for Mantle Cell Lymphoma. According to GlobalData,...

Data Insights

Tinostamustine by Mundipharma EDO for T-Cell Leukemia: Likelihood of Approval

Tinostamustine is under clinical development by Mundipharma EDO and currently in Phase I for T-Cell Leukemia. According to GlobalData, Phase...